ZCM
ENZ

Zebra Capital Management’s Enzo Biochem, Inc. ENZ Stock Holding History

Zebra Capital Management’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-10,056
Closed -$26K – 290
2019
Q4 		$26K Buy
+10,056
New +$30K 0.02% 288

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Zebra Capital Management's ENZ Position: Q1 2020 in Review

Zebra Capital Management sold out of Enzo Biochem, Inc. (ENZ) in Q1 2020, closing a stake of 10,056 shares — an estimated $26K sold.

Zebra Capital Management first reported a position in ENZ in Q4 2019 and held it in 1 quarter. The position peaked at $26K in Q4 2019. 76 funds tracked by Wall St. Rank hold ENZ as of Q1 2020.

  • Zebra Capital Management reported no remaining Enzo Biochem, Inc. position as of Q1 2020 after selling out during the quarter.
  • Zebra Capital Management sold 10,056 Enzo Biochem, Inc. shares in Q1 2020, an estimated $26K.
  • Zebra Capital Management first reported a position in Enzo Biochem, Inc. in Q4 2019 and held it in 1 quarter.
  • Zebra Capital Management's Enzo Biochem, Inc. position peaked at $26K in Q4 2019.
  • 76 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2020.

Based on Zebra Capital Management's 13F filing for Q1 2020, filed 15 May 2020.